PCSK9 and cancer: Since we observed that targeting cholesterol-modulating PCSK9 enzyme with its specific PF-06446846 inhibitor could impair OC cancer cell survival, we decided to investigate the cytotoxic effect of other compounds involved in lipid-metabolism (Table 2) in OC cell lines and PDCs.